Sort
4,870 grants matching “glp 1”
Modulating prostaglandin E2 receptor activity to improve pancreatic islet function
$0Maureen A Gannon · Veterans Health Administration · I01 · FY2022 · VA
Core--Cell Processing and Gene Therapy Facility
$0Johns Hopkins University · P30 · FY2001 · CA
Mechanisms of glucagon-like peptide 1 (GLP-1) in fatty liver disease
$0Frank A. Anania · Veterans Health Administration · I01 · FY2014 · VA
Gut Neuroendocrine Cell Signaling and Obesity
$0Rodger A. Liddle · Durham Va Medical Center · I01 · FY2017 · VA
Gut Neuroendocrine Cell Signaling and Obesity
$0Rodger A. Liddle · Durham Va Medical Center · I01 · FY2014 · VA
The role of the androgen receptor in insulin secretion
$0Franck Mauvais-Jarvis · Southeast Louisiana Veterans Health Care · I01 · FY2020 · VA
Role of Nutrient Sensing Receptors for the Gut Microbiota in Metabolism
$0Brian Thomas Layden · Jesse Brown Va Medical Center · I01 · FY2022 · VA
EFFECTS OF GLP ON GLUCOSE EFFECTIVENESS
$0Mayo Clinic Coll Of Medicine, Rochester · M01 · FY2001 · RR
Gut Neuroendocrine Cell Signaling and Obesity
$0Rodger A. Liddle · Durham Va Medical Center · I01 · FY2016 · VA
Comparative Effectiveness and Safety of Newer and Older Antihyperglycemic Medications
$0Ziyad Al-Aly · St. Louis Va Medical Center · I01 · FY2025 · VA
Luminal factors affecting duodenal protection and chemosensing
$0Jonathan D. Kaunitz · Va Greater Los Angeles Healthcare System · I01 · FY2015 · VA
Impaired glucose utilization and behavior in a mouse model of chronic, mild TBI
$0June Zhou · U.S. Dept/Vets Affairs Medical Center · I21 · FY2017 · VA
Pharmacological Restoration of Diabetic Vascular Dysfunction
$0Jane E Reusch · Va Eastern Colorado Health Care System · I01 · FY2016 · VA
Regulation of insulin Secretion by the GLP-1 Receptor
$0David A. D'alessio · Durham Va Medical Center · I01 · FY2019 · VA
Effectiveness of Hypoglycemic Medications Among Veterans with CKD
$0Christianne L. Roumie · Veterans Health Administration · I01 · FY2023 · VA
Targeting Microvascular Contributors to Impaired Functional Exercise Capacity in Diabetes
$0Jane E Reusch · Va Eastern Colorado Health Care System · I01 · FY2022 · VA
Enteroendocrine cell reprogramming during intestinal injury
$0Brian David Muegge · St. Louis Va Medical Center · IK2 · FY2023 · VA
Pharmacological Restoration of Diabetic Vascular Dysfunction
$0Jane E Reusch · Va Eastern Colorado Health Care System · I01 · FY2015 · VA
Metabolic regulation of islet hormone secretion in diabetes
$0Matthew J. Merrins · Wm S. Middleton Memorial Veterans Hosp · I01 · FY2025 · VA
Impaired glucose utilization and behavior in a mouse model of chronic, mild TBI
$0June Zhou · U.S. Dept/Vets Affairs Medical Center · I21 · FY2015 · VA
EFFECTS OF GLP 1 ON INSULIN ACTION IN DIABETIC &NON DIABETIC SUBJECTS
$0Mayo Clinic Coll Of Medicine, Rochester · M01 · FY2001 · RR
Role of the Androgen Receptor in Insulin Secretion in the Male
$0Franck Mauvais-Jarvis · Southeast Louisiana Veterans Health Care · I01 · FY2025 · VA
Impaired glucose utilization and behavior in a mouse model of chronic, mild TBI
$0June Zhou · U.S. Dept/Vets Affairs Medical Center · I21 · FY2016 · VA
GLUCAGON LIKE PEPTIDE 1 (GPL 1) IN GLUCOSE HOMEOSTASIS
$0University Of Washington · M01 · FY2001 · RR
CORE--BIOPROCESS AND PURIFICATION
$0University Of Virginia Charlottesville · U54 · FY2002 · HD